Confirmed COVID-19 infection – Page 2 – Communicable Diseases Research

Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study

Research article

Published on 2022-05-012022-10-05
Journal: Respiratory medicine and research [Category] COVID19(2023년), SARS, 바이오마커,

Blood myxovirus resistance protein-1 measurement in the diagnostic work-up of suspected COVID-19 infection in the emergency department

Observational Study

Published on 2022-04-012022-10-04
Journal: Immunity, Inflammation and Disease [Category] 임상,

Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19

COVID-19에 감염된 임산부에서 HNP-1, HBD-1 및 HBD-4에 대한 진단 및 치료 가능성

Article

Published on 2022-03-222022-09-11
Journal: International Journal of Molecular Sciences [Category] 유전자 메커니즘,

[키워드] affected Alpha AMPs anti-inflammatory cytokine antimicrobial peptide antimicrobial peptides Beta Biochemistry biological activities characterized Coagulation Confirmed COVID-19 infection COVID-19 COVID-19 infection cytokine cytokine profile Cytokines defensin Defensins deficiency defined ELISA assay evaluated fetus Gene Expression generate help highlight IL-10 IL-2 IL-6 IL-8 immune immune system immunological change increase in Infection innate immune system Interleukins involved Laboratory Laboratory medicine lipoprotein lipoprotein-a mechanism mother peptides Potential Pregnancy pregnant women pro-inflammatory factor pro-inflammatory factors problem problems PROTECT risk factor TGF-β TNF-α virus attacks Vitamin vitamins with COVID-19
[DOI] 10.3390/ijms23073450 PMC 바로가기 [Article Type] Article

Distinct etiologies of high-sensitivity troponin T elevation predict different mortality risks for patients hospitalized with COVID-19

고감도 트로포닌 T 상승의 독특한 병인은 COVID-19로 입원한 환자의 다른 사망률 위험을 예측합니다

Article

Published on 2022-03-152022-09-11
Journal: International journal of cardiology [Category] MERS, SARS, 바이오마커,

[키워드] 95% CI Acute heart failure arrhythmia Arrhythmias association cardiac Cardiac biomarkers cardiovascular cardiovascular event Cardiovascular events Confirmed COVID-19 infection COVID-19 COVID-19 infection Critical Critical illness elevated etiology event Evidence evidence of heart failure identify increased risk Infarction large cohort Logistic regression analysis Mortality mortality rate mortality risk Myocardial infarction negative patient occurred outcomes Patient patients patients hospitalized predict predictor regression analysis renal renal failure retrospective risk sensitivity significantly higher significantly increased single hospital study population troponin was performed was used with COVID-19
[DOI] 10.1016/j.ijcard.2021.12.029 PMC 바로가기 [Article Type] Article

Characteristics and impact of Long Covid: Findings from an online survey

Research Article

Published on 2022-03-082022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

[키워드] age agglomerative hierarchical clustering analysed Analysis antibody baseline Belonging Cardiopulmonary carried Characteristics Chest Cluster Clusters cognitive collected comparison Confirmed COVID-19 infection COVID-19 COVID-19 illness described duration of illness dysfunction enrolled exhibiting exploratory female finding functional headache Health heterogeneity highlight hospitalised identify Infection initial initial symptom interquartile range IQR Long majority median MOST multisystem symptoms palpitation participant PCR predictor predominant Prevalence prevalent Prognosis public health relapsing reported Research Result SARS-COV-2 infection Shortness of breath Sleep disturbance specific symptom Standard deviation Stress Symptom Symptoms triggered was used
[DOI] 10.1371/journal.pone.0264331 PMC 바로가기 [Article Type] Research Article

Comparison of Outcomes and Process of Care for Patients Treated at Hospitals Dedicated for COVID-19 Care vs Other Hospitals

Research

Published on 2022-03-032022-10-29
Journal: JAMA Network Open [Category] COVID-19, MERS, SARS,

[키워드] 95% CI analyses association Care Cohort cohort study collected Complication Confirmed COVID-19 infection Corticosteroid COVID-19 demographic characteristics evaluate evaluated exposure finding High-dose hospital hospitals Importance In-hospital in-hospital mortality Infection Logistic regression lower mortality measure median age men Mortality mortality rate multivariate objective Odds ratio Other outcome pandemic Pandemics participant Patient patients treated patients with COVID-19 performed Point Primary outcome Process propensity score matching reducing Relevance Remdesivir Result retrospective cohort study Secondary outcomes setting significantly higher significantly lower study period Support System the SARS-CoV-2 Thrombosis prophylaxis Tocilizumab treated Treatment women
[DOI] 10.1001/jamanetworkopen.2022.0873 PMC 바로가기 [Article Type] Research

Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2

SARS-CoV-2의 델타 변종(B.1.617.2)에 대한 연령별 감수성

Article

Published on 2022-03-012022-09-11
Journal: JAMA Network Open [Category] SARS, 변종,

[키워드] 95% CI age analyzed association B.1.617.2 Bayesian inference children compartmental model Confirmed COVID-19 infection Contact Contact tracing COVID-19 COVID-19 infections COVID-19 pandemic COVID-19 vaccination Delta delta variant diagnosed with COVID-19 diagnostic distribution doubling Effectiveness force of infection highest increase in individual Infection knowledge latent period outcome quarantine remained SARS-CoV-2 significant difference South Korea strain Strains study period susceptibility susceptible symptom onset vaccination Vaccination Status Vaccine variant was used were excluded
[DOI] 10.1001/jamanetworkopen.2022.3064 PMC 바로가기 [Article Type] Article

Association between tracheostomy timing and outcomes for older critically ill COVID-19 patients: prospective observational study in European intensive care units

Clinical Trial

Published on 2022-03-012022-10-05
Journal: British journal of anaesthesia [Category] 임상,

[키워드] 95% CI 95% confidence interval age Analysis association clinical Clinical outcome concerning Confirmed COVID-19 infection COVID-19 COVID-19 patient Critically ill Critically ill patient Europe European European country evaluate Evidence expected Final hazard ratio healthcare intensive care intensive care unit intensive care units intubation Invasive mechanical ventilation landmark analysis mechanical ventilation Mortality no difference Older outcome outcome assessment Patient patients patients with COVID-19 performed primary analysis prospective cohort study prospective observational study survival the timing tracheostomy Trial Variation was performed with COVID-19
[DOI] 10.1016/j.bja.2021.11.027 PMC 바로가기 [Article Type] Clinical Trial

Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile

COVID-19의 중병 예방을 위한 회복기 혈장: 2상 시험 및 면역 프로필

Clinical Trial

Published on 2022-02-232022-09-10
Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, 치료법, 치료제,

[키워드] 28-day mortality 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered administration Admission Alter anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibodies antibody Antibody Response Antibody titers Antiviral effect antiviral effects baseline caused circulating co-morbidities co-morbidity comparable Confirmed COVID-19 infection Control controls convalescent plasma coronavirus COVID-19 COVID-19 infection COVID-19 pandemic Critical Critical illness Critically ill death demographics Dexamethasone group hazard ratio Hospital admission ICU IgA level illness immune initial Level morbidities non-critically ill patient non-critically ill patients non-ICU pandemic Pandemics participant Patient PCR Phase 2 Planning plasma populations Preventing profile progression provide reduce reduced reduction in Remdesivir respiratory Respiratory disease Respiratory failure respiratory symptom respiratory symptoms respiratory tract SARS-CoV-2 severe acute respiratory syndrome Coronavirus significantly increased single-arm specific antibody statistically significant difference suggestion target protein target proteins tested transfer transfused transfusion Treatment Trial with COVID-19
[DOI] 10.1128/spectrum.02560-21 PMC 바로가기 [Article Type] Clinical Trial

High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department

응급실에서 COVID-19 감염 환자의 집중 치료실 입원 및 사망률 증가와 관련된 높은 Procalcitonin 수준

Research Article

Published on 2022-02-212022-09-10
Journal: BMC Infectious Diseases [Category] COVID19(2023년), Fulltext, MERS, SARS, 바이오마커,

[키워드] 105 patient 105 patients 95% CI 95% confidence interval acute respiratory distress acute respiratory distress syndrome adjusted Admission age Analysis ARDS assist association AUC Bacterial bacterial coinfections Biomarker Biomarkers C-reactive protein C-reactive protein (CRP calculate center clinical decision Comorbidities Comorbidity Confirmed COVID-19 infection COVID-19 COVID-19 infection COVID-19 infections CRP D-dimer Decision making decision making process defined develop elevated emergency department Erasmus Final final analysis hospital discharge Hospital mortality hyperinflammation ICU ICU admission in-hospital mortality intensive care intensive care unit Logistic regression Mortality multivariable model Netherlands Odds ratio outcome Patient patients with COVID-19 PCT physician Primary outcome procalcitonin procalcitonin level reached required respiratory distress Respiratory distress syndrome Result retrospective cohort study Severe COVID-19 Infection severe COVID-19 infections Sex significantly supplementary material syndrome were measured
[DOI] 10.1186/s12879-022-07144-5 PMC 바로가기 [Article Type] Research Article